HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancerRubén Olivera‐Salguero, Tomás Pascual, Cristina Saura et al.|Frontiers in Oncology|2023Cited by 4
Abstract LB1-06: Primary results of SOLTI VALENTINE: neoadjuvant randomized phase II trial of HER3-DXd alone or in combination with letrozole for high-risk hormone receptor positive (HR+)/HER2-negative (neg) early breast cancer (EBC)Mafalda Oliveira, Aleix Prat, Tomás Pascual et al.|Clinical Cancer Research|2025Cited by 3
195P Health-related quality of life outcomes in SOLTI VALENTINE: A trial of neoadjuvant HER3-DXd +/- letrozole for high-risk hormone receptor positive/HER2-negative early breast cancerGuillermo Villacampa, Ana Muntañola Prat, Mikele Praia de Oliveira et al.|ESMO Open|2025Cited by 1
Abstract PO4-14-02: Enhancing Informative Outcomes with Liquid Biopsy in a Real-World Population of Patients with Advanced Breast Cancer: Analysis of the SOLTI-1903 HOPE StudyTomás Pascual, Aleix Prat, Elia Seguí et al.|Cancer Research|2024Cited by 0